多西米蒂
DOCS
30.97
-0.53
-1.68%
多西米蒂
US · DOCS
#2122 按市值排名
上市于 2021
30.97
-0.53
-1.68%
实时 - 追踪5344个代码 - 心跳于449秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期(2026/Q3)披露持股的机构数量减少了1家。
- 机构持股总比例上升了0.7个百分点。
机构持股
- 机构持股比例
- 74.23% +0.65pp
- 机构数量
- 443 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund42.86%
Individual/Insider28.87%
Hedge Fund16.90%
Public Company5.33%
Private Company3.43%
Government Pension Fund2.07%
VC/PE Fund1.59%
Sovereign Wealth Fund1.06%
Insurance Company0.73%
主要股东 截至 2026-08-15
Jeffrey Tangney
27.96% · 49.84M 股
BlackRock
8.03% · 14.31M 股
Vanguard Capital Management, LLC
3.83% · 6.82M 股
Vanguard Portfolio Management, LLC
3.58% · 6.39M 股
D. E. Shaw & Co., L.P.
3.32% · 5.92M 股
Two Sigma Investments, LP
2.61% · 4.65M 股
State Street Global Advisors
2.36% · 4.21M 股
Geode Capital Management, LLC
2.16% · 3.85M 股
The Goldman Sachs Group, Inc.
1.92% · 3.43M 股
Wellington Management Group
1.76% · 3.14M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 17次买入 · 32次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Jeffrey Tangney | Co-Founder, CEO & Chairperson | 27.96% |
| Anna Bryson | Chief Financial Officer | 0.34% |
| Kevin Spain | Independent Director | 0.14% |
| Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | 0.04% |
| Regina Benjamin | Independent Director | 0.02% |
| Matthew Sonefeldt | CFO & Principal Financial Officer | 0.02% |
| Kira Wampler | Independent Director | 0.01% |
| Phoebe L. Watkin | Independent Director | 0.01% |
| Steven Zatz | President | 0.01% |
| Timothy Cabral | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Kira Wampler | Independent Director | Derivative Exercise and Sale | -2,000 | $28.91 |
| 2026-09-29 | Phoebe L. Watkin | Independent Director | Automatic Disposition | -1,290 | $26.71 |
| 2026-09-23 | Steven Zatz | President | Other Acquisition | +152,427 | -- |
| 2026-09-14 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Derivative Exercise and Sale | -5,000 | -- |
| 2026-09-14 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Derivative Exercise and Sale | -2,077 | $26.02 |
| 2026-09-14 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Derivative Exercise and Retained | +2,923 | -- |
| 2026-08-31 | Kira Wampler | Independent Director | Derivative Exercise and Sale | -2,000 | $26.33 |
| 2026-08-26 | Regina Benjamin | Independent Director | Other Acquisition | +8,084 | -- |
| 2026-08-26 | Timothy Cabral | Independent Director | Other Acquisition | +8,084 | -- |
| 2026-08-26 | Kevin Spain | Independent Director | Other Acquisition | +8,084 | -- |
| 2026-08-26 | Kira Wampler | Independent Director | Other Acquisition | +8,084 | -- |
| 2026-08-26 | Phoebe L. Watkin | Independent Director | Other Acquisition | +8,084 | -- |
| 2026-08-24 | Kira Wampler | Independent Director | Derivative Exercise and Sale | -2,000 | $24.95 |
| 2026-08-14 | Steven Zatz | President | Sale to Issuer | -4,482 | $24.80 |
| 2026-08-14 | Jeffrey Tangney | Co-Founder, CEO & Chairperson | Sale to Issuer | -8,505 | $24.80 |
| 2026-08-14 | Matthew Sonefeldt | CFO & Principal Financial Officer | Sale to Issuer | -15,311 | $24.80 |
| 2026-08-14 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Derivative Exercise and Sale | -5,000 | $24.80–24.94 |
| 2026-08-14 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Sale to Issuer | -652 | $24.80 |
| 2026-08-12 | Siddharth Sitaram | Chief Accounting Officer and Interim Principal Financial & Accounting Officer | Derivative Exercise and Sale | -5,000 | -- |
| 2026-08-06 | Timothy Cabral | Independent Director | Derivative Exercise and Sale | -7,500 | $39.11 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
多西米蒂 讨论区 0 条评论